Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 88 for “"Aβ aggregation"”.
-
Endocannabinoids as Amyloid-Beta (Aβ) Aggregation Inhibitors
… Alzheimer's disease, which is characterized by Aβ aggregation-induced cell toxicity, inflammation, tau phosphorylation, disruption of neurotransmitters pathways, mitochondrial dysfunction, and oxidative stress. The endocannabinoids, such as 2-AG, AEA, NADA, noladin, OAE, and their main …
-
Stimulators of Aβ aggregation identified through drug screening
… amyloid fibril core that is formed through self-aggregation of the P-amyloid peptide (AP), a proteolytic product of amyloid precursor protein (APP). AP aggregation is currently thought to play a causative role in the development of AD, and thus is an attractive target for potential therapeutics. …
-
Piperine Derivatives as Modulators of Amyloid-Beta (Aβ) Aggregation
… the economy. A major factor leading to AD is the aggregation of a protein known as amyloid-β (Aβ). However, most pharmacotherapies for AD provide only symptomatic relief and target other pathways. The recently approved monoclonal antibodies (mAbs) are the only disease-modifying therapies targeting …
-
Novel 1,4-Diazepane Derivatives as Amyloid Beta (Aβ) Aggregation Inhibitors
… driven by the accumulation of amyloid-β (Aβ) plaques and tau tangles in the brain. The Aβ aggregation is indeed the primary pathological event, playing a key role in the initiation and progression of the disease. Despite extensive research, effective disease-modifying treatments remain …
-
Yeast as a Model for Studying Aβ Aggregation, Toxicity and Clearance
… of these amyloid deposits is the amyloid beta (Aβ) protein. The Aβ protein is a 40 or 42 amino acid cleavage product of APP (Amyloid Precursor Protein) which is produced in low levels in the normal ageing brain. Although senile amyloid plaques is the major pathological hallmark of AD brains, …
-
Molecular basis of Amyloid Disease : In silico modelling of Beta-Amyloid (Aβ) aggregation
… to the Amyloid hypothesis, AD is caused by the aggregation of neurotoxic Aβ which is cleaved from the C-terminal of a very large protein, the amyloid precursor protein (APP). A molecular-level understanding is critical to understanding the development and progression of AD. Whilst …
-
Einfluss der Gravidität und Laktation auf die Aβ-Aggregation und die adulte Neurogenese in einem Tiermodell für Morbus Alzheimer
… von Gravidität und Laktation auf die Amyloid-β-Aggregation, Proliferation und adulte Neurogenese im Hippokampus zu untersuchen. Hierfür wurde ein Alzheimer-Mausmodell verwendet (5xFAD), das fünf humane Mutationen in den Genen für das Amyloid-Vorläuferprotein (APP) und für Präsenilin 1 (PS1) …
-
Einfluss von Trächtigkeit und environmental enrichment auf die Aβ-Aggregation, die adulte Neurogenese und Mikrogliazellen in einem transgenen Mausmodell für Morbus Alzheimer
… Wirkung der Gravidität auf die Anzahl der Aβ-Plaques in Cortex und Hippocampus anhand zweier Fluoreszenzfärbungen bestätigt werden. Eine in Vorergebnis-sen mittels DCX-Immunhistochemie nachgewiesene Einschränkung der adulten Neuro-genese im Hippocampus nach durchlaufener Gravidität (P20) …
-
Discovery and Characterization of Multi-Target Directed Ligands as Inhibitors of Amyloid-β Aggregation and Regulators of Alzheimer's Disease
… of AD. Numerous factors, including amyloid-β (Aβ) aggregation, calcium homeostasis dysregulation, and oxidative stress, contribute to disease development and interplay with each other. Therefore, multi-target directed ligands (MTDLs) may present an effective AD treatment. Among all factors, Aβ …
-
Development of peptide inhibitor nanoparticles (PINPs) for treatment of Alzheimer’s Disease
… the best carrier technology for our β-amyloid (Aβ) aggregation inhibitors by developing three types of liposomes (a) plain liposomes, (b) MAL-PEG liposomes, and finally the combination of retro-inverted peptide RI-OR2- TAT (Ac-rGffvlkGrrrrqrrkkrGyc-NH2) attached onto the surface of MAL-PEG …
-
Role of misfolded SOD1 in neurodegenerative diseases
… to degrade misfolded SOD1. On the other hand, Aβ protein aggregation is widely observed in the pathogenesis of Alzheimer’s disease (AD) and considered as an initial step of the formation of amyloid plaques. The mechanism of Aβ aggregation remains to be revealed. Increasing studies suggest that …
-
γ -AAPeptides Targeting Amyloid-β Pathway and Neural Repair for Alzheimer’s Disease Treatment
… by the accumulation of amyloid-beta (Aβ) plaques and progressive neuronal degeneration. Despite extensive research, no treatments have been able to effectively halt or reverse the progression of the disease. This study aimed to evaluate the therapeutic potential of two novel …
-
Peptoid-Based KLVFF Mimics: A Unique Approach to Alzheimer's Disease
… of amyloid plaques that develop from the aggregation of the amyloid beta protein (Aβ) in the body. Current treatment options for AD has been the development of compounds that can target and either inhibit or modulate the formation of Aβ aggregates. Several small molecules and peptides have …
-
Study of Polyphenols and Naphthalimide Analogs As Inhibitors of Amyloid- β Protein Aggregation In Alzheimer'S Disease
… β proteins (A β). Inhibition of the formation of Aβ aggregates or disrupting pre-formed Aβ aggregates is widely considered to be a promising disease-modifying therapy. In this study, a group of polyphenols, including flavone, apigenin, luteolin, 3'4'-dihydroxyflavone and …
-
Stilbenes: Therapeutic Interventions Targeting Amyloid β Protein Aggregation In Alzheimer’s Disease
… and subsequent aggregating of amyloid-β (Aβ) peptide. This aggregation process converts non-toxic functional Aβ peptides into a spectrum of neurotoxic Aβ aggregated species, such as, oligomers, soluble aggregates and fibrils. These aggregated forms are believed to be the source of …
-
Understanding Amyloid β Aggregation and the Interaction with Ions via Supercritical Angle Microspectroscopy
… The proper understanding of Amyloid β (Aβ) aggregation which commonly associated with AD is the state-of-the-art for the development of therapeutics and diagnostics. The supercritical angle optical technique takes the advantage of evanescent wave phenomena, offers excellent surface …
-
Endocytic Trafficking of The Amyloid Precursor Protein In Rat Cortical Neurons
Amyloid-beta (Aβ) aggregation and deposition into extracellular plaques is a hallmark of the most common forms of dementia, including Alzheimer’s disease. The Aβ-containing plaques result from pathogenic cleavage of amyloid precursor protein (APP) by secretases resulting in intracellular production …
-
Anthranilate Analogs as a Druggable Target for the Proteopathy and Immunopathy of Alzheimer's Disease
β-Amyloid (Aβ) triggered proteopathic and immunopathic processes are a postulated cause of Alzheimer’s disease (AD). Monomeric Aβ is derived from amyloid precursor protein, whereupon it aggregates into various assemblies, including oligomers and fibrils, which disrupt neuronal membrane integrity …
-
Leveraging Photoactive Molecules to Study Amyloid-β Aggregates and Diffusion of Two-dimensional Nanomaterials
… to investigate two main topics: amyloid-β (Aβ) aggregates and hydrodynamics of two-dimensional (2D) nanomaterials. Chapter 1 summarizes the general concepts in the thesis: photoactive probes, Aβ peptide, and hexagonal boron nitride (h-BN) nanosheets. Section 1.1 will outline the logic for …
-
Cross-Interactions of Amyloid Proteins: Implications for Aggregation Dynamics and Disease Pathology
Amyloid aggregation is a pervasive form of protein misfolding implicated in the pathology of several prominent human diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and type 2 diabetes (T2D). These diseases are marked by the accumulation of amyloid fibrils and toxic …
Page 1 of 5